Biotech Steals The Show Following Pre-Clinical Data Announcement
2024年3月28日 - 4:35AM
AllPennyStocks.com
A California-based biotech company stirred
things up on Wednesday after it was announced the publication of
preclinical data on its lead clinical compound, LB-100.
To read the full story on AllPennyStocks.com, click
here.
Lixte Biotechnology (NASDAQ:LIXT)
過去 株価チャート
から 4 2024 まで 5 2024
Lixte Biotechnology (NASDAQ:LIXT)
過去 株価チャート
から 5 2023 まで 5 2024